{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+Gel", "query": { "intervention": "Vehicle Gel" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 218, "total_pages": 22, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+Gel&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-06T05:26:20.124Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04155190", "title": "A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Basal Cell Carcinoma" ], "interventions": [ { "name": "Patidegib Topical Gel, 2%", "type": "DRUG" }, { "name": "Patidegib Topical Gel, Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2019-12-20", "completion_date": "2021-04-23", "has_results": true, "last_update_posted_date": "2026-07-21", "last_synced_at": "2026-09-06T05:26:20.124Z", "location_count": 14, "location_summary": "Apple Valley, California • Colton, California • Fremont, California + 11 more", "locations": [ { "city": "Apple Valley", "state": "California" }, { "city": "Colton", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04155190" }, { "nct_id": "NCT04769648", "title": "Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Ocular Graft-versus-host Disease" ], "interventions": [ { "name": "Pro-ocular™ Topical Gel 1%", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Glia, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2021-04-15", "completion_date": "2023-10-15", "has_results": false, "last_update_posted_date": "2023-03-24", "last_synced_at": "2026-09-06T05:26:20.124Z", "location_count": 1, "location_summary": "Needham, Massachusetts", "locations": [ { "city": "Needham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04769648" }, { "nct_id": "NCT05062070", "title": "Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Epidermolysis Bullosa Simplex" ], "interventions": [ { "name": "TolaSure Topical Gel", "type": "DRUG" }, { "name": "Vehicle Topical Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioMendics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2022-05-05", "completion_date": "2023-06-22", "has_results": false, "last_update_posted_date": "2023-09-11", "last_synced_at": "2026-09-06T05:26:20.124Z", "location_count": 1, "location_summary": "Redwood City, California", "locations": [ { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05062070" }, { "nct_id": "NCT04088357", "title": "Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Wound Healing" ], "interventions": [ { "name": "TolaSure Topical Gel", "type": "DRUG" }, { "name": "Topical Vehicle Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioMendics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2019-08-26", "completion_date": "2020-04-22", "has_results": false, "last_update_posted_date": "2021-06-24", "last_synced_at": "2026-09-06T05:26:20.124Z", "location_count": 2, "location_summary": "Miami, Florida • College Station, Texas", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "College Station", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04088357" }, { "nct_id": "NCT02393937", "title": "A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Papulopustular Rosacea", "Erythematotelangiectatic Rosacea" ], "interventions": [ { "name": "Reference: Metronidazole Gel 1%", "type": "DRUG" }, { "name": "Test: Metronidazole Gel 1%", "type": "DRUG" }, { "name": "Placebo Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "bioRASI, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 963, "start_date": "2015-02", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2020-09-03", "last_synced_at": "2026-09-06T05:26:20.124Z", "location_count": 27, "location_summary": "Los Angeles, California • San Diego, California • Boca Raton, Florida + 23 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02393937" }, { "nct_id": "NCT03667222", "title": "Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Papulopustular Rosacea" ], "interventions": [ { "name": "minocycline topical gel", "type": "DRUG" }, { "name": "topical gel vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioPharmX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 207, "start_date": "2018-09-18", "completion_date": "2019-08-17", "has_results": false, "last_update_posted_date": "2019-07-10", "last_synced_at": "2026-09-06T05:26:20.124Z", "location_count": 12, "location_summary": "Anaheim Hills, California • Miami, Florida • Miramar, Florida + 9 more", "locations": [ { "city": "Anaheim Hills", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miramar", "state": "Florida" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03667222" }, { "nct_id": "NCT02865005", "title": "Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Dapsone 5.0% Gel (SEEGPharm)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Dapsone 5.0% Gel (Allergan)", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Seegpharm S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Years to 40 Years" }, "enrollment_count": 2361, "start_date": "2016-02", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2016-12-20", "last_synced_at": "2026-09-06T05:26:20.124Z", "location_count": 35, "location_summary": "Encino, California • Fullerton, California • La Mesa, California + 29 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02865005" }, { "nct_id": "NCT05190770", "title": "A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "Breast Cancer Stage", "Breast Cancer Stage I", "Breast Cancer Stage II", "Breast Cancer Stage III", "Breast Cancer Stage IV" ], "interventions": [ { "name": "Triamcinolone Acetonide", "type": "DRUG" }, { "name": "Oleogel-S10", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2021-12-15", "completion_date": "2024-08-27", "has_results": true, "last_update_posted_date": "2025-12-03", "last_synced_at": "2026-09-06T05:26:20.124Z", "location_count": 4, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Harrison, New York + 1 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Harrison", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05190770" }, { "nct_id": "NCT06690177", "title": "Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Venus Leg Ulcers" ], "interventions": [ { "name": "EscharEx (EX-03)", "type": "DRUG" }, { "name": "Placebo (Gel vehicle)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MediWound Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2025-04-30", "completion_date": "2028-09-30", "has_results": false, "last_update_posted_date": "2024-11-15", "last_synced_at": "2026-09-06T05:26:20.124Z", "location_count": 1, "location_summary": "Carlsbad, California", "locations": [ { "city": "Carlsbad", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06690177" }, { "nct_id": "NCT01493687", "title": "Phase 3 Papulopustular Rosacea Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Papulopustular Rosacea (PPR)" ], "interventions": [ { "name": "CD5024", "type": "DRUG" }, { "name": "Azelaic acid 15% Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 683, "start_date": "2011-12", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-09-06T05:26:20.124Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Rogers, Arkansas • Los Angeles, California + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01493687" } ] }